Macquarie Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01K | Hold |
|
|||||
|
2025
Q1 | $4.82K | Hold |
|
|||||
|
2024
Q4 | $4.29K | Hold |
|
|||||
|
2024
Q3 | $4.61K | Sell |
|
|||||
|
2024
Q2 | $13.5M | Sell |
|
|||||
|
2024
Q1 | $31.2M | Sell |
|
|||||
|
2023
Q4 | $34.9M | Sell |
|
|||||
|
2023
Q3 | $58.2M | Sell |
|
|||||
|
2023
Q2 | $60.2M | Sell |
|
|||||
|
2023
Q1 | $64.4M | Buy |
|
|||||
|
2022
Q4 | $59.8M | Sell |
|
|||||
|
2022
Q3 | $51.8M | Sell |
|
|||||
|
2022
Q2 | $57.1M | Sell |
|
|||||
|
2022
Q1 | $60.5K | Buy |
|
|||||
|
2021
Q4 | $51M | Sell |
|
|||||
|
2021
Q3 | $76.9M | Sell |
|
|||||
|
2021
Q2 | $79.8M | Buy |
|
|||||
|
2021
Q1 | $78.5M | Buy |
|
|||||
|
2020
Q4 | $77.6M | Buy |
|
|||||
|
2020
Q3 | $70.9M | Sell |
|
|||||
|
2020
Q2 | $75.2M | Sell |
|
|||||
|
2020
Q1 | $76.5M | Sell |
|
|||||
|
2019
Q4 | $101M | Sell |
|
|||||
|
2019
Q3 | $91.2M | Sell |
|
|||||
|
2019
Q2 | $97.5M | Buy |
|
|||||
|
2019
Q1 | $97.4M | Buy |
|